Drug intelligence / Profile preview

Trencam-3,2-Hopo

Development stage
Preclinical
Lead developer
Pfizer
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Trencam-3,2-Hopo is a synthetic small molecule belonging to the class of salicylamides and is structurally related to hydroxypyridinone (HOPO) chelators. It acts as a multidentate chelating agent capable of binding metal ions such as iron and various radiometals. The compound has been studied primarily for its ability to form stable complexes with metals for use in targeted imaging and potential therapeutic applications, particularly in the context of radiopharmaceuticals for positron emission tomography (PET). Trencam-3,2-Hopo derivatives have been evaluated as bifunctional chelators that can be conjugated to targeting moieties (such as PSMA ligands) for selective delivery of radiometals like gallium-68 or titanium-45 to tumors expressing specific antigens[1][5][8]. Its mechanism involves strong coordination with metal ions via its HOPO groups; this property underlies its utility both in diagnostic imaging and potentially in decorporation therapy or MRI contrast enhancement[1][8].

02

Targets

GA (Glycated albumin)

Beyond the preview

Go deeper on Trencam-3,2-Hopo.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trencam-3,2-Hopo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call